Autopsy report · NCT01733095

Ambrisentan for Treatment of Portopulmonary Hypertension

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1, Phase 2
Sponsor: Medical University of Graz
Sponsor type: University, hospital or other
Conditions: Portopulmonary Hypertension
Interventions: ambrisentan
Participants: 0
Sites: 1
Countries: Austria

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.